Life Sciences Conversion and Innovation Center Arrives in Frederick, Maryland



All new R&D Spec Suites lab to come

FRÉDÉRIC, MD., July 15, 2021 / PRNewswire-PRWeb / – Beckham Gumbin Ventures (BGV), a commercial real estate investor and developer, begins construction of brand new R&D lab suites and facilities at Ballenger Bio (321 Ballenger Center Drive) in Frédéric, Maryland. Ballenger Bio will offer multiple R&D lab specification suites from 3,000 to 7,000 square feet, with the ability to combine up to 37,000 square feet of contiguous space on a single floor. Building such specification labs will allow growing biotech companies to focus on their business rather than cost and time to build.

The life sciences industry in suburban Maryland remains robust with a vacancy rate of less than 4%. Many smaller and start-up life science companies have nowhere to pitch their flag given the high demand and low supply of real estate to meet their specialized needs. This is especially true in Frederick County, where space in the ready-to-move-in BSL-2 lab is extremely limited.

BGV, an experienced life sciences developer who recently converted a 285,000 square foot complex into Rockville, Maryland, recognized the growing needs of life science companies in Frederick. Paul grayson de BGV explained, “While there are other developers bringing a quick-to-market concept for larger biotech manufacturing needs, Ballenger Bio will be the solution for small bio R&D and chemistry labs. and medium size that are needed in the market. We are excited about the opportunity to support Frédéric’s strong biotechnology community, which includes some of the most advanced biomedical research laboratories in the world. “

the City of Frédéric Mayor Michael o’connor shared, “The Frederick The region is now one of the largest groupings of life sciences companies in the country. By providing speculative laboratory space in Frederick, Ballenger Bio will expand opportunities for companies to grow alongside world-renowned public research facilities such as Fort Detrick and the Frederick National Laboratory for Cancer Research and join our more than 80 biotechnology companies in Frederick. The City appreciates BGV’s investment in Ballenger Bio and we look forward to working with these new companies in Frederick! “

the City of Frédéric The Ministry of Economic Development works closely with companies considering new operations in Frederick and provides connectivity to resources and programs. Director of Economic Development, Richard griffin said, “The life science ecosystem here has received a lot of attention due to Frédéric’s quality of life and highly skilled workforce. Amenities such as a historic and trendy downtown, a thriving arts and entertainment scene, and more than 80 state, county and municipal parks help position Frederick as a great place to live and work. We look forward to welcoming future businesses to join our nearly 3,700 businesses across the city. “

BGV has hired Cushman & Wakefield to lead its rental efforts and plans to deliver these labs by early 2022.

About Beckham Gumbin Ventures:

Beckham Gumbin Ventures, LLC (BGV) is a commercial real estate investment and development company that pursues real estate investments primarily in the largest Washington DC and Phoenix, Arizona metropolitan areas. With over 75 years of combined experience, BGV’s principals have been active investors, owners and developers of properties across North America. The BGV team’s experience covers almost all types of commercial real estate and all levels of the capital structure.

About Cushman & Wakefield:
Cushman & Wakefield (NYSE: CWK) is a leading global real estate services company delivering exceptional value to real estate occupants and owners. Cushman & Wakefield is one of the world’s largest real estate services companies with approximately 51,000 employees in 400 offices and 70 countries. In 2018, the company achieved a turnover of $ 8.2 billion through basic property, facilities and project management, leasing, capital markets, appraisal and other services. To learn more, visit http://www.cushmanwakefield.com or follow @CushWake on Twitter.

Media contact

Megan Williams, Cushman Wakefield, 240 506 5609, [email protected]

SOURCE Beckham Gumbin Ventures


Previous Adicet Bio announces the formation of a scientific council
Next Global Report on Size, Share, Trends and Forecasts - The Manomet Current

No Comment

Leave a reply

Your email address will not be published.